|
1
|
Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group.
|
Ann Surg
|
1999
|
3.56
|
|
2
|
Patients with penile carcinoma benefit from immediate resection of clinically occult lymph node metastases.
|
J Urol
|
2005
|
2.31
|
|
3
|
How to avoid false-negative dynamic sentinel node procedures in penile carcinoma.
|
J Urol
|
2004
|
2.29
|
|
4
|
[Guideline 'Melanoma' (3rd revision)].
|
Ned Tijdschr Geneeskd
|
2005
|
2.08
|
|
5
|
Anatomy and physiology of lymphatic drainage of the breast from the perspective of sentinel node biopsy.
|
J Am Coll Surg
|
2001
|
1.79
|
|
6
|
Reliability of sentinel lymph node biopsy for staging melanoma.
|
Br J Surg
|
2000
|
1.71
|
|
7
|
Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: A systematic review and meta-analysis of the literature.
|
Eur J Surg Oncol
|
2008
|
1.69
|
|
8
|
Positive iliac and obturator nodes in melanoma: survival and prognostic factors.
|
Ann Surg Oncol
|
1999
|
1.55
|
|
9
|
Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbs.
|
J Am Coll Surg
|
1996
|
1.54
|
|
10
|
Palliative isolated limb perfusion for advanced limb disease in stage IV melanoma patients.
|
J Surg Oncol
|
2005
|
1.52
|
|
11
|
Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience.
|
Ann Surg
|
1996
|
1.51
|
|
12
|
High incidence of in-transit metastases after sentinel node biopsy in patients with melanoma.
|
Br J Surg
|
2004
|
1.46
|
|
13
|
Safety and efficacy of isolated limb perfusion in elderly melanoma patients.
|
Ann Surg Oncol
|
2002
|
1.46
|
|
14
|
Excision biopsy of breast lesions changes the pattern of lymphatic drainage.
|
Br J Surg
|
2007
|
1.43
|
|
15
|
[Detailed pathological examination of the sentinel lymph nodes in order to detect micrometastases: no clinical relevance in patients with breast cancer].
|
Ned Tijdschr Geneeskd
|
2004
|
1.40
|
|
16
|
Finding lymph node metastases in invasive breast cancer: sampling or sentinel node procedure?
|
Eur J Surg Oncol
|
2002
|
1.39
|
|
17
|
[Less mutilating treatment of penile carcinoma].
|
Ned Tijdschr Geneeskd
|
2005
|
1.35
|
|
18
|
Evaluation of mammary lymphoscintigraphy by a single intratumoral injection for sentinel node identification.
|
J Nucl Med
|
2000
|
1.25
|
|
19
|
Frozen section investigation of the sentinel node in malignant melanoma and breast cancer.
|
Ann Surg Oncol
|
2001
|
1.19
|
|
20
|
Detection of unknown occult primary tumors using positron emission tomography.
|
Cancer
|
1998
|
1.18
|
|
21
|
Morbidity of dynamic sentinel node biopsy in penile carcinoma.
|
J Urol
|
2005
|
1.15
|
|
22
|
Localizing the sentinel node in cutaneous melanoma: gamma probe detection versus blue dye.
|
Ann Surg Oncol
|
1997
|
1.13
|
|
23
|
Clinical relevance of sentinel lymph nodes outside the axilla in patients with breast cancer.
|
Br J Surg
|
2000
|
1.13
|
|
24
|
The hidden sentinel node in breast cancer.
|
Eur J Nucl Med Mol Imaging
|
2002
|
1.10
|
|
25
|
History of sentinel node and validation of the technique.
|
Breast Cancer Res
|
2001
|
1.05
|
|
26
|
Single intralesional tracer dose for radio-guided excision of clinically occult breast cancer and sentinel node.
|
Ann Surg Oncol
|
2001
|
1.04
|
|
27
|
Positron emission tomography for staging of oesophageal and gastroesophageal malignancy.
|
Br J Cancer
|
1998
|
1.01
|
|
28
|
Detection of occult metastasis in squamous cell carcinoma of the penis using a dynamic sentinel node procedure.
|
J Urol
|
2000
|
0.98
|
|
29
|
The health-related quality of life of long-term survivors of melanoma treated with isolated limb perfusion.
|
Eur J Surg Oncol
|
2007
|
0.98
|
|
30
|
Vascular complications of isolated limb perfusion.
|
Eur J Surg Oncol
|
1998
|
0.97
|
|
31
|
Reliability of lymphoscintigraphy in indicating the number of sentinel nodes in melanoma patients.
|
Ann Surg Oncol
|
2000
|
0.96
|
|
32
|
Sentinel node biopsy for melanoma in the head and neck region.
|
Head Neck
|
2000
|
0.96
|
|
33
|
Lymphatic mapping and sentinel node biopsy in Merkel's cell carcinoma.
|
Eur J Surg Oncol
|
2006
|
0.94
|
|
34
|
The luminescence immunoassay S-100: a sensitive test to measure circulating S-100B: its prognostic value in malignant melanoma.
|
Br J Cancer
|
1998
|
0.94
|
|
35
|
The illusion of the learning phase for lymphatic mapping.
|
Ann Surg Oncol
|
2002
|
0.93
|
|
36
|
Sentinel nodes outside lymph node basins in patients with melanoma.
|
Br J Surg
|
2001
|
0.93
|
|
37
|
Severe acute regional toxicity after normothermic or 'mild' hyperthermic isolated limb perfusion with melphalan for melanoma.
|
Melanoma Res
|
1995
|
0.93
|
|
38
|
Temozolomide followed by combined immunotherapy with GM-CSF, low-dose IL2 and IFN alpha in patients with metastatic melanoma.
|
Br J Cancer
|
2003
|
0.92
|
|
39
|
Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy.
|
Br J Surg
|
2007
|
0.92
|
|
40
|
Fluorine-18-fluorodeoxyglucose assessment of glucose metabolism in bone tumors.
|
J Nucl Med
|
1998
|
0.92
|
|
41
|
Eight false negative sentinel node procedures in breast cancer: what went wrong?
|
Eur J Surg Oncol
|
2003
|
0.91
|
|
42
|
Relation between limb toxicity and treatment outcomes after isolated limb perfusion for recurrent melanoma.
|
J Am Coll Surg
|
1999
|
0.90
|
|
43
|
Identification and biopsy of the sentinel lymph node in breast cancer.
|
Eur J Surg Oncol
|
1998
|
0.90
|
|
44
|
Thirty-five years of isolated limb perfusion for melanoma: indications and results.
|
Br J Surg
|
1996
|
0.90
|
|
45
|
Absence of severe systemic toxicity after leakage-controlled isolated limb perfusion with tumor necrosis factor-alpha and melphalan.
|
Ann Surg Oncol
|
1999
|
0.89
|
|
46
|
Dynamic sentinel node biopsy for penile cancer: reliability of a staging technique.
|
J Urol
|
2002
|
0.89
|
|
47
|
Lymphatic mapping with intralesional tracer administration in breast carcinoma patients.
|
Cancer
|
2000
|
0.89
|
|
48
|
Impact of non-axillary sentinel node biopsy on staging and treatment of breast cancer patients.
|
Br J Cancer
|
2002
|
0.89
|
|
49
|
Complications of combined radiotherapy and isolated limb perfusion with tumor necrosis factor alpha +/- interferon gamma and melphalan in patients with irresectable soft tissue tumors.
|
J Surg Oncol
|
1997
|
0.88
|
|
50
|
Toxicity and morbidity of isolated limb perfusion.
|
Semin Surg Oncol
|
1998
|
0.88
|
|
51
|
Improved sentinel node visualization in breast cancer by optimizing the colloid particle concentration and tracer dosage.
|
Nucl Med Commun
|
2001
|
0.87
|
|
52
|
Long-term functional morbidity after mild hyperthermic isolated limb perfusion with melphalan.
|
Eur J Surg Oncol
|
1999
|
0.86
|
|
53
|
Detection of local recurrence of soft-tissue sarcoma with positron emission tomography using [18F]fluorodeoxyglucose.
|
Ann Surg Oncol
|
1997
|
0.85
|
|
54
|
Management of clinically node negative penile carcinoma: improved survival after the introduction of dynamic sentinel node biopsy.
|
J Urol
|
2003
|
0.84
|
|
55
|
Technique of sentinel node biopsy in breast cancer.
|
Eur J Surg Oncol
|
1998
|
0.84
|
|
56
|
Regional toxicity after isolated limb perfusion with melphalan and tumour necrosis factor- alpha versus toxicity after melphalan alone.
|
Eur J Surg Oncol
|
2001
|
0.84
|
|
57
|
Sentinel node detection in head and neck malignancies: innovations in radioguided surgery.
|
J Oncol
|
2009
|
0.84
|
|
58
|
Lymphoscintigraphy in oncology: a rediscovered challenge.
|
Eur J Nucl Med
|
1999
|
0.83
|
|
59
|
Metabolism of a [18F]fluorine labeled progestin (21-[18F]fluoro-16 alpha-ethyl-19-norprogesterone) in humans: a clue for future investigations.
|
Nucl Med Biol
|
1994
|
0.83
|
|
60
|
Repeat isolated limb perfusion with TNFalpha and melphalan for recurrent limb melanoma after failure of previous perfusion.
|
Eur J Surg Oncol
|
2006
|
0.82
|
|
61
|
Standardized uptake value and quantification of metabolism for breast cancer imaging with FDG and L-[1-11C]tyrosine PET.
|
J Nucl Med
|
1997
|
0.82
|
|
62
|
False negative sentinel node procedure established through palpation of the biopsy wound.
|
Eur J Surg Oncol
|
2000
|
0.82
|
|
63
|
Reproducibility of lymphoscintigraphy for lymphatic mapping in cutaneous melanoma.
|
J Nucl Med
|
1996
|
0.82
|
|
64
|
Validation of gamma probe detection of the sentinel node in melanoma.
|
J Nucl Med
|
1997
|
0.81
|
|
65
|
Sensitivity of sentinel node biopsy in melanoma.
|
J Surg Oncol
|
2001
|
0.81
|
|
66
|
57Co-bleomycin and 67Ga-citrate in detecting and staging lung cancer.
|
Thorax
|
1983
|
0.81
|
|
67
|
Prognostic factors for survival after isolated limb perfusion for malignant melanoma.
|
Eur J Surg Oncol
|
2003
|
0.80
|
|
68
|
Detection of lung cancer with 55Co-bleomycin using a positron camera. A comparison with 57Co-bleomycin and 55Co-bleomycin single photon scintigraphy.
|
Eur J Nucl Med
|
1982
|
0.80
|
|
69
|
Value of serum S-100B for prediction of distant relapse and survival in stage III B/C melanoma.
|
Anticancer Res
|
2008
|
0.80
|
|
70
|
Major amputation for intractable extremity melanoma after failure of isolated limb perfusion.
|
Eur J Surg Oncol
|
2005
|
0.79
|
|
71
|
Radio-guided surgery improves outcome of therapeutic excision in non-palpable invasive breast cancer.
|
Nucl Med Commun
|
2004
|
0.79
|
|
72
|
Systemic toxicity after isolated limb perfusion with melphalan for melanoma.
|
Eur J Surg Oncol
|
1996
|
0.78
|
|
73
|
The value of Cloquet's node in predicting melanoma nodal metastases in the pelvic lymph node basin.
|
Ann Surg Oncol
|
2001
|
0.78
|
|
74
|
Physiological implications of hyperbaric oxygen tensions in isolated limb perfusion using melphalan: a pilot study.
|
Eur Surg Res
|
1996
|
0.78
|
|
75
|
Improved staging of breast cancer through lymphatic mapping and sentinel node biopsy.
|
Eur J Surg Oncol
|
1998
|
0.78
|
|
76
|
No evidence of benefit from class-II compression stockings in the prevention of lower-limb lymphedema after inguinal lymph node dissection: results of a randomized controlled trial.
|
Lymphology
|
2013
|
0.77
|
|
77
|
Principles and guidelines for surgeons: management of cutaneous malignant melanoma. European Society of Surgical Oncology Brussels.
|
Eur J Surg Oncol
|
1997
|
0.77
|
|
78
|
FDG-PET to evaluate response to hyperthermic isolated limb perfusion for locally advanced soft-tissue sarcoma.
|
J Nucl Med
|
1996
|
0.77
|
|
79
|
Hyperthermic isolated limb perfusion for the treatment of soft tissue sarcomas.
|
Semin Surg Oncol
|
1998
|
0.77
|
|
80
|
Value of laboratory tests in monitoring acute regional toxicity after isolated limb perfusion.
|
Ann Surg Oncol
|
1997
|
0.77
|
|
81
|
Hyperthermic isolated limb perfusion with tumour necrosis factor and melphalan as treatment of locally advanced or recurrent soft tissue sarcomas of the extremities.
|
Radiother Oncol
|
1998
|
0.77
|
|
82
|
Prognosis in patients with sentinel node-positive melanoma without immediate completion lymph node dissection.
|
Br J Surg
|
2012
|
0.77
|
|
83
|
Radiation absorbed doses from Co-57- and Co-55 bleomycin.
|
J Nucl Med
|
1984
|
0.76
|
|
84
|
Topical dinitrochlorobenzene combined with systemic dacarbazine in the treatment of recurrent melanoma.
|
Melanoma Res
|
1997
|
0.76
|
|
85
|
Management of malignant melanoma.
|
Ann Chir Gynaecol
|
2000
|
0.76
|
|
86
|
Penile lymphoscintigraphy for sentinel node identification.
|
Eur J Nucl Med
|
2001
|
0.76
|
|
87
|
PET with L-[1-carbon-11]-tyrosine to visualize tumors and measure protein synthesis rates.
|
J Nucl Med
|
1997
|
0.76
|
|
88
|
[Guideline 'Melanoma' (3rd revision)].
|
Ned Tijdschr Geneeskd
|
2005
|
0.75
|
|
89
|
[Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
|
Ned Tijdschr Geneeskd
|
2004
|
0.75
|
|
90
|
Multicentre validation study of sentinel node biopsy for staging in breast cancer (Br J Surg 2005; 92: 1221-1224).
|
Br J Surg
|
2006
|
0.75
|
|
91
|
[Concealed local recurrence after breast-conserving treatment].
|
Ned Tijdschr Geneeskd
|
2002
|
0.75
|
|
92
|
An original approach in the diagnosis of early breast cancer: use of the same radiopharmaceutical for both non-palpable lesions and sentinel node localisation.
|
Eur J Nucl Med Mol Imaging
|
2002
|
0.75
|
|
93
|
The sentinel node procedure in patients with melanoma.
|
Eur J Surg Oncol
|
2004
|
0.75
|
|
94
|
[A decade of sentinel lymph node biopsy for breast cancer: time for adaptations].
|
Ned Tijdschr Geneeskd
|
2008
|
0.75
|
|
95
|
Sentinel-node biopsy in breast cancer.
|
Lancet
|
1997
|
0.75
|
|
96
|
Letter to the editor concerning 'intradermal radioisotope injection optimises sentinel lymph node identification in breast cancer'.
|
Eur J Surg Oncol
|
2004
|
0.75
|
|
97
|
[Summary of the guideline 'Sentinel Lymph Node Biopsy for Breast Cancer'].
|
Ned Tijdschr Geneeskd
|
2001
|
0.75
|
|
98
|
Reproducibility of cutaneous lymphoscintigraphy: same or different lymphatic routes and sentinel nodes after reinjection?
|
J Nucl Med
|
2001
|
0.75
|
|
99
|
Re: Gad D, Hoiland-Carlesen PF, Bartram P, et al.: staging patients with cutaneous malignant melanoma by same day lymphoscintigraphy and sentinel lymph node biopsy: a single-institutional experience with emphasis on recurrence.
|
J Surg Oncol
|
2006
|
0.75
|
|
100
|
Sentinel-node biopsy sampling in breast cancer.
|
Lancet
|
2000
|
0.75
|
|
101
|
L-[1-11C]-tyrosine PET to evaluate response to hyperthermic isolated limb perfusion for locally advanced soft-tissue sarcoma and skin cancer.
|
J Nucl Med
|
1999
|
0.75
|
|
102
|
[The role of sentinel node biopsies in the treatment of patients with breast carcinoma].
|
Ned Tijdschr Geneeskd
|
1996
|
0.75
|
|
103
|
Scintigraphy with 57Co-bleomycin in the detection of lung cancer. A review of 268 well-documented patients.
|
Cancer
|
1984
|
0.75
|
|
104
|
A response to Lee M. Ellis's editorial: A perspective on sentinel lymph node biopsy in colorectal cancer: the race between surgical technology and molecular oncology.
|
Ann Surg Oncol
|
2001
|
0.75
|
|
105
|
[Regional isolated perfusion: also applicable in elderly patients].
|
Ned Tijdschr Geneeskd
|
2003
|
0.75
|
|
106
|
Current status of sentinel lymph node biopsy in patients with melanoma.
|
Rozhl Chir
|
2014
|
0.75
|
|
107
|
Cervical lymph-node metastasis from cutaneous melanoma of the head and neck: a search for prognostic factors.
|
Eur J Surg Oncol
|
1998
|
0.75
|
|
108
|
[Applications of positron-emission tomography in oncology].
|
Ned Tijdschr Geneeskd
|
1996
|
0.75
|
|
109
|
L-[1-carbon-11]tyrosine imaging of metastatic testicular nonseminoma germ-cell tumors.
|
J Nucl Med
|
1998
|
0.75
|
|
110
|
[Results of 25-year pheochromocytoma treatment in the Groningen Academic Hospital].
|
Ned Tijdschr Geneeskd
|
1997
|
0.75
|
|
111
|
Lymphoscintigraphy of a breast tumor showing focal tracer accumulation along the falciform ligament of the liver.
|
Clin Nucl Med
|
2010
|
0.75
|
|
112
|
Carbon dioxide laser for cutaneous melanoma metastases: indications and limitations.
|
Eur J Surg Oncol
|
1997
|
0.75
|
|
113
|
[Regional lymph nodes at a distance].
|
Ned Tijdschr Geneeskd
|
2008
|
0.75
|
|
114
|
Rationale for different approaches to combined melphalan and hyperthermia in regional isolated perfusion.
|
Eur J Cancer
|
1997
|
0.75
|
|
115
|
Isolated limb perfusion with melphalan for femoral metastases of breast cancer: case report.
|
J Surg Oncol
|
2002
|
0.75
|
|
116
|
[Detection of metastatic melanoma in sentinel lymph nodes by means of polymerase chain reaction].
|
Ned Tijdschr Geneeskd
|
1998
|
0.75
|
|
117
|
Lymphatic mapping and selective lymphadenectomy for melanoma: not yet standard therapy.
|
Eur J Surg Oncol
|
1997
|
0.75
|
|
118
|
The sentinel node biopsy in patients with breast cancer; many controversies remain.
|
Eur J Gynaecol Oncol
|
2006
|
0.75
|
|
119
|
How to do sentinel node biopsy in breast cancer.
|
Ann Chir Gynaecol
|
2000
|
0.75
|